Investors / Spain / Asabys Partners
Asabys Partners
Venture capital · Barcelona, Spain · Europe
Asabys Partners is an investment firm based in Barcelona that invests in healthcare and life-sciences innovation. It describes itself as a hands-on partner to its portfolio companies and integrates ESG considerations into its investment processes.
Invests inHealthcare & Biotech
In its own wordshealthcarelife sciencesbiotechmedical devicesdigital healththerapeutics
Your fit with Asabys Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAsabys Partners lists 23 checked portfolio companies on its own site and is named in 7 funding rounds, 2 of them as lead. Its most frequent entry is Series B, 43% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 60% of its companies are based in Spain. It invests most often alongside AdBio partners, Sofinnova Partners and Ysios Capital.
Counts come from funding rounds that name Asabys Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Asabys Partners' whole history. Rounds on record name 7 companies; its own site lists 23. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundAsabys Partners does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 29% |
| Series A | 14% |
| Series B | 43% |
| Growth | 14% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 3 | 1 |
| '26 | 4 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 57th | 23 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 61th | 29% of entries at pre-seed or seed |
| Evidence | 93th | 22% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 78th | 5 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| AdBio partners | 3 |
| Sofinnova Partners | 3 |
| Ysios Capital | 3 |
| Amadeus Capital Partners | 2 |
| Convergence Partners | 2 |
| Criteria Bio Ventures | 2 |
| MD Start | 2 |
| Prous Institute for Biomedical Research | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers23100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Asabys Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Asabys Partners| Date | Company | Stage |
|---|---|---|
| 29 Oct 2026 | Seed Led | |
| 2 Sept 2026 | Seed | |
| 4 Jun 2026 | Series B | |
| 10 Sept 2025 | Series C+ Led | |
| 11 Jun 2025 | Series B | |
| 24 Mar 2025 | Series A |
Round details for Asabys Partners
Amounts, full round histories and every co-investor in Asabys Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
23 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Accure Therapeutics is a R&D pharma company dedicated to developing innovative medicines to treat patients suffering from Central nervous system (CNS) diseases | Healthcare & Biotech | Portfolio page | ||
| Agomab is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for fibro-inflammatory diseases. | Healthcare & Biotech | Portfolio page | ||
| The company harnesses the power of genetics and AI to learn the biophysical parameters governing protein function. | Healthcare & Biotech | Oct 2026Seed | Page + round | |
| Augustine Therapeutics develops novel HDAC6 inhibitors for the treatment of chronic diseases | Healthcare & Biotech | Mar 2025Series A | Page + round | |
| Deepull is developing technology to detect sepsis-causing pathogens and antibiotic resistance markers directly from blood | Healthcare & Biotech | Portfolio page | ||
| Gradient Denervation Technologies develops a minimally invasive, ultrasound-based device for the treatment of pulmonary hypertension. | Healthcare & Biotech | Portfolio page | ||
| Inbiomotion develops a test to help select breast cancer patients for adjuvant treatment with bisphosphonates | Healthcare & Biotech | Portfolio page | ||
| INBRAIN Neuroelectronics decodes neural signals and translates them into intelligent autonomous therapy | Healthcare & Biotech | Portfolio page | ||
| iPremom develops a test to evaluate the risk of preeclampsia in pregnancy | Healthcare & Biotech | Sept 2026Seed | Funding round | |
| Medasense develops and provides products for pain management, including the PMD-200 | Healthcare & Biotech | Portfolio page | ||
| Mediktor provides an all-in-one platform for patient management using AI technology | Healthcare & Biotech | Portfolio page | ||
| Binx Health develops and provides a point-of-care STI testing platform for clinics and healthcare organizations. | Healthcare & Biotech | Portfolio page | ||
| Nuage Therapeutics is developing new cancer therapies by targeting disordered proteins | Healthcare & Biotech | Portfolio page | ||
| Ona Therapeutics develops first-in-class antibody drug conjugates to treat advanced cancer. | Healthcare & Biotech | Jun 2026Series B | Page + round | |
| Orikine Bio develops precision-engineered, bi-specific cytokines to treat autoimmune and inflammatory diseases | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Peptomyc is developing a Myc inhibitor to treat cancer | Healthcare & Biotech | Portfolio page | ||
| Qida provides home care services for elderly people, including caregiver services and accompaniment to hospitals. | Healthcare & Biotech | Portfolio page | ||
| Quibim designs pioneering tools that unlock imaging data to improve patient outcomes | Healthcare & Biotech | Portfolio page | ||
| SafeHeal is a clinical stage medical device manufacturer that develops anastomosis protection devices for colorectal surgery | Healthcare & Biotech | Sept 2025Series C+ | Page + round |
About this data
site last read 5 Nov 2026- Site
- asabys.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 24 Mar 2025
- Companies checked
- 23
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Asabys Partners' profile as data
Pull Asabys Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/asabys.com
# also
GET /v1/firms/asabys.com/portfolio
GET /v1/firms/asabys.com/coinvestors
GET /v1/firms/asabys.com/news